Method for Testing for Human Papillomavirus Infection in Patients with Cervical Intraepithelial Disease

Journal of Clinical Microbiology

Volumn 42, Issue 1, 2004, Pages 366-368

  Lin, Hsing Pei ^a   Huang, Yang Yang ^a   Wu, Hsueh Yin ^a   Kao, Jau Tsuen ^b,c,d  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b Graduate Institute of Medical Science   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DNA DETERMINATION; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; PAPILLOMA VIRUS; PRIORITY JOURNAL; RECURRENT DISEASE; RELIABILITY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX DISEASE; UTERINE CERVIX EPITHELIUM; VIRUS INFECTION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL DISEASES;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRUS;

EID: 0346462939     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.1.366-368.2004     Document Type: Article

References (18)

1. Bosch, F. X., M. M. Manos, N. Munoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, and K. V. Shah. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87:796-802.
2. Clavel, C., M. Masure, J. P. Bory, I. Putaud, C. Mangeonjean, M. Lorenzato, R. Gabriel, C. Quereux, and P. Birembaut. 1999. Hybrid Capture 11-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women. Br. J. Cancer 80:1306-1311.
3. Clavel, C., M. Masure, J. P. Bory, I. Putaud, C. Mangeonjean, M. Lorenzato, P. Nazeyrollas, R. Gabriel, C. Quereux, and P. Birembaut. 2001. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br. J. Cancer 84:1616-1623.
4. Cox, J. T., A. T. Lorincz, M. H. Schiffman, M. E. Sherman, A. Cullen, and R. J. Kurman. 1995. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am. J. Obstet. Gynecol. 172: 946-954.
5. Cuzick, J., E. Beverley, L. Ho, G. Terry, H. Sapper, I. Mielzynska, A. Lorincz, W. K. Chan, T. Krausz, and P. Soutter. 1999. HPV testing in primary screening of older women. Br. J. Cancer 81:554-558.
6. de Villiers, E. M., and A. Ruhland. 2001. Do specific human papillomavirus types cause psoriasis? Arch. Dermatol. 137:384.
7. Franco E. L., L. L. Villa, and J. P. Sobrinho. 1999. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J. Infect. Dis. 180:1415-1423.
8. Herrero, R., A. Hildesheim, C. Bratti, M. E. Sherman, M. Hutchinson, J. Morales, I. Balmaceda, M. D. Greenberg, M. Alfaro, R. D. Burk, S. Wacholder, M. Plummer, and M. Schiffman. 2000. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J. Natl. Cancer Inst. 92:464-474.
9. Ho, G. Y., R. Bierman, L. Beardsley, C. J. Chang, and R. D. Burk. 1998. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 338:423-428.
10. Lorincz, A. T., P. E. Castle, M. E. Sherman, D. R. Scott, A. G. Glass, S. Wacholder, B. B. Rush, P. E. Gravitt, J. E. Schussler, and M. Schiffman. 2002. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 360:228-229.
11. National Cancer Institute. 1989. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnosis. JAMA 262:931-934.
12. Rozendaal, L., J. M. Walboomers, J. C. van der Linden, F. J. Voorhorst, P. Kenemans, T. J. Helmerhorst, M. van Ballegooijen, and C. J. Meijer. 1996. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int. J. Cancer 68:766-769.
13. Saslow D., C. D. Runowicz, D. Solomon, A. B. Moscicki, R. A. Smith, H. J. Eyre, and C. Cohen. 2002. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA-Cancer J. Clin. 52:342-362.
14. Schiffman, M., R. Herrero, A. Hildesheim, M. E. Sherman, M. Bratti, S. Wacholder, M. Alfaro, M. Hutchinson, J. Morales, M. D. Greenberg, and A. T. Lorincz. 2000. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 283:87-93.
15. Schneider, A., and L. A. Koutsky. 1992. Natural history and epidemiological features of genital HPV infection. IARC Sci. Publ. 119:25-52.
16. Schneider, A., D. M. Zahm, R. Kirchmayr, and V. L. Schneider. 1996. Screening for cervical intraepithelial neoplasia grade 2/3: validity of cytologic study, cervicography, and human papillomavirus detection. Am. J. Obstet. Gynecol. 174:1534-1541.
17. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. Snijders, J. Peto, C. J. Meijer, and N. Munoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.
18. World Health Organization. 2002. Deaths by cause, sex and mortality stratum in WHO regions, estimates for 2001, p. 186-191. In The world health report 2002: reducing risks, promoting healthy life. World Health Organization, Geneva, Switzerland.